Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Thrombin Market: By Product: Bovine Thrombin, Human Thrombin, Recombinant Thrombin; By Dosage Form: Powder Form, Solution Form; By End User: Hospitals, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Thrombin Market Outlook

The global thrombin market attained a value of more than USD 578.5 million in 2021. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 4.22% to reach over USD 741.3 million by 2027.

 

Global Thrombin Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to Witness a Considerable Growth of the Thrombin Industry

North America holds a considerable share of the thrombin industry owing to the increasing prevalence of road accidents in the region. The growing incidences of trauma cases are surging the demand for thrombin, hence driving the market growth. The increasing prevalence of genetically inherited blood disorders such as inherited thrombophilia, especially among the Caucasian and Scandinavian population, is surging the risk for thrombosis, which is further adding to the growth of the industry.

Moreover, the rising disposable income of the population and well established healthcare infrastructure are providing lucrative growth opportunities to the thrombin industry. The growing presence of leading companies like Pfizer inc. and Johnson & Johnson Services Inc., among others, in the region are increasing research and development (R&D) activities of thrombin, which is providing further impetus to the growth of the market.

 

Thrombin: Market Segmentation

Thrombin refers to a naturally occurring enzyme that converts fibrinogen into fibrin to enable the clotting of blood. It is usually derived from prothrombin and is typically used as a topical haemostatic agent. Moreover, thrombin is utilised in near larger vessels to prevent disseminated intravascular coagulation (DIC) and death in surgeries.

 

Global Thrombin Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major products of thrombin are:

  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin

Based on dosage form, the market is bifurcated into:

  • Powder Form
  • Solution Form

By end user, the market is divided into:

  • Hospitals
  • Diagnostics Centre and Clinics
  • Academics and Research Institutes

The EMR report looks into the regional markets of thrombin like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Thrombin Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Haemophilia to Bolster the Market Growth of Thrombin

The rising prevalence of haemophilia in both developed and developing countries is surging the utilisation of thrombin in its treatment, which is fuelling the market growth. The extensive use of thrombin in the healthcare sector owing to the rising incidences of surgical haemostatic is driving the market growth. As the risk of blood clotting during thrombin is very high, the use of thrombin as a haemostatic ancillary is growing, thereby augmenting the industry growth.

The development of thrombin from alternative sources owing to the increasing bleeding complications of bovine thrombin is expected to propel the industry growth. With the growing availability of recombinant and human thrombin, their popularity is increasingly growing among surgeons to prevent the risk of antigenicity, which is predicted to bolster the industry growth. The increasing approvals of innovative thrombin by health organisations such as the Food and Drug Administration (FDA) is estimated to significantly contribute to the growth of the market in the forecast period.

 

Key Industry Players in the Global Thrombin Market

The report presents a detailed analysis of the following key players in the global thrombin market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc.
  • Johnson and Johnson Services Inc.
  • Baxter International, Inc.
  • Shanghai RAAS Blood Products Co., Ltd.
  • Japan Blood Products Organization
  • Mochida Pharmaceutical Co., Ltd
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Dosage Form, End User, Region
Breakup by Product Bovine Thrombin, Human Thrombin, Recombinant Thrombin
Breakup by Dosage Form Powder Form, Solution Form
Breakup by End User Hospitals, Diagnostics Centre and Clinics, Academics and Research Institutes
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., Johnson and Johnson Services, Inc., Baxter International, Inc.,
Shanghai RAAS Blood Products Co., Ltd., Japan Blood Products Organization, Mochida Pharmaceutical Co., Ltd, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Thrombin Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Thrombin Historical Market (2017-2021) 
    8.3    Global Thrombin Market Forecast (2022-2027)
    8.4    Global Thrombin Market by Product
        8.4.1    Bovine Thrombin
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Human Thrombin
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Recombinant Thrombin
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Thrombin Market by Dosage Form
        8.5.1    Powder Form
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Solution Form
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Thrombin Market by End User
        8.6.1    Hospitals
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Diagnostics Centre and Clinics
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Academics and Research Institutes
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
    8.7    Global Thrombin Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Pfizer Inc.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Johnson and Johnson Services, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Baxter International, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Shanghai RAAS Blood Products Co., Ltd.
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Japan Blood Products Organization
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Mochida Pharmaceutical Co., Ltd
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Thrombin Market: Key Industry Highlights, 2017 and 2027
2.    Global Thrombin Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Thrombin Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Thrombin Historical Market: Breakup by Dosage Form (USD Million), 2017-2021
5.    Global Thrombin Market Forecast: Breakup by Dosage Form (USD Million), 2022-2027
6.    Global Thrombin Historical Market: Breakup by End User (USD Million), 2017-2021
7.    Global Thrombin Market Forecast: Breakup by End User (USD Million), 2022-2027
8.    Global Thrombin Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Thrombin Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Thrombin Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Thrombin Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Thrombin Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Thrombin Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Thrombin Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Thrombin Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Thrombin Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Thrombin Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Thrombin Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Thrombin Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Thrombin Market Structure

Key Questions Answered in the Report

In 2021, the global thrombin market attained a value of more than USD 578.5 million.

The market is estimated to grow at a CAGR of 4.22% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach above USD 741.3 million by 2027.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the market include the growing incidences of road accidents and increasing prevalence of haemophilia.

The growing R&D activities in the healthcare industry in the emerging economies is expected to be a key trend guiding the growth of the industry.

The major products available in the market are bovine thrombin, human thrombin, and recombinant thrombin.

The different forms of dosage in the market are powder form and solution form.

The different end users are hospitals, diagnostics centre and clinics, and academics and research institutes.

The major players in the industry are Pfizer Inc., Johnson and Johnson Services Inc., Baxter International, Inc., Shanghai RAAS Blood Products Co., Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co., Ltd, among others.

Analyst Review

The global thrombin market attained a value of more than USD 578.5 million in 2021, driven by the rising cases of haemophilia. Aided by the technological advancements in the healthcare industry in the emerging economies, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 4.22%. The market is projected to reach over USD 741.3 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the market is divided into bovine thrombin, human thrombin, and recombinant thrombin. On the basis of dosage form, the market is divided into powder form and solution form. By end user, the market has been segmented into hospitals, diagnostics centre and clinics, and academics and research institutes. The major regional markets for thrombin are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Johnson and Johnson Services Inc., Baxter International, Inc., Shanghai RAAS Blood Products Co., Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co., Ltd, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER